m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00640)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
CYLD
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
YTH domain-containing protein 2 (YTHDC2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Smoking-related downregulation of YTHDC2 was associated with enhanced proliferation and migration in lung cancer cells, YTHDC2 functions as a tumor suppressor through the Ubiquitin carboxyl-terminal hydrolase CYLD (CYLD)/NF-Kappa-B signaling pathway, which is mediated by m6A modification. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Pathway Response | NF-kappa B signaling pathway | hsa04064 | ||
In-vitro Model | NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 |
BEAS-2B | Normal | Homo sapiens | CVCL_0168 | |
In-vivo Model | Approximately 5×106 normal H1299 cells or stable YTHDC2-overexpressing H1299 cells were implanted subcutaneously into the right flank of the animals (n=8 mice per group). Animals were euthanized by cervical dislocation ~30 days after implantation, and tumors were collected and photographed. | |||
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Smoking-related downregulation of YTHDC2 was associated with enhanced proliferation and migration in lung cancer cells, YTHDC2 functions as a tumor suppressor through the Ubiquitin carboxyl-terminal hydrolase CYLD (CYLD)/NF-Kappa-B signaling pathway, which is mediated by m6A modification. | |||
Responsed Disease | Lung cancer [ICD-11: 2C25] | |||
Target Regulator | YTH domain-containing protein 2 (YTHDC2) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | NF-kappa B signaling pathway | hsa04064 | ||
In-vitro Model | NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 |
BEAS-2B | Normal | Homo sapiens | CVCL_0168 | |
In-vivo Model | Approximately 5×106 normal H1299 cells or stable YTHDC2-overexpressing H1299 cells were implanted subcutaneously into the right flank of the animals (n=8 mice per group). Animals were euthanized by cervical dislocation ~30 days after implantation, and tumors were collected and photographed. | |||